

Vita RT10 10mg
- Compound
- Reta
- Strength
- 10 mg per vial
- Pack
- 1 vial
- Total
- 10 mg
- Half-life
- About 6 days
- Form
- Freeze-dried powder
- Ships from inside Canada
- Tracking within 72 hours
- Free Canada Post shipping over $300
- Plain, unbranded box
Vita RT10 10mg in Canada
Vita RT10 contains Reta, an experimental peptide injected once a week. It works on three receptors at once: GLP-1, GIP and glucagon. It is still in late-stage trials and has no approval in any country.
What you get: one vial holding 10 mg of freeze-dried powder, which you mix with bacteriostatic water before use. Priced in Canadian dollars and shipped from within Canada.
Why people buy it
- Research on weight loss and metabolic disease
How Reta works
Two of its targets, GLP-1 and GIP, cut appetite and help the pancreas release insulin. The third, glucagon, increases how much energy the body burns and how much fat the liver uses up. In a phase 2 trial that ran for 48 weeks, people on the highest dose lost about 24% of their weight on average.
Half-life: about 6 days.
Clinical reference dose
Phase 2 trials began at 2 mg once a week and raised the dose every 4 weeks until people reached targets of 4–12 mg a week. There is no approved use of any kind.
Mixing: put 2 ml of bacteriostatic water into this 10 mg vial and the strength becomes 5 mg per ml. Each 10 units (0.1 ml) on a U-100 insulin syringe then carries 0.5 mg.
In the trials, heart rate went up, and it went up more as the dose rose.
These figures come from product labels and clinical studies. They are a point of reference, not advice for you personally; a doctor works out your dose from your own bloodwork.
Combinations and interactions
Often compared or used with
- Usually measured against TZ5 (GLP-1/GIP) and semaglutide (GLP-1).
- Do not use two incretin peptides together.
Interactions to know
- Insulin and sulfonylureas: blood sugar can drop too low.
- Oral medicines: the way they are absorbed may change.
Before adding anything new, give your doctor and pharmacist the full list of what you take, supplements included.
Side effects and risks
Stomach effects
Nausea, vomiting and diarrhea, which get worse as the dose goes up.
Heart rate
Resting heart rate rises.
Unknown long-term safety
Trials are not yet finished.
Injection safety
Each injection needs a fresh sterile needle and syringe. Clean the stopper and your skin with alcohol, and never share equipment. If redness, warmth or swelling is getting worse after a day or two, it may be an infection and a doctor should look at it.
Have had medullary thyroid cancer or MEN 2, or it runs in your family; have had pancreatitis; have type 1 diabetes; or are pregnant.
In Canada: Health Canada has not approved Reta for human use. It is sold as a research peptide.
Bloodwork checklist
- A1C and fasting glucose
- Kidney function (creatinine, eGFR)
- Liver panel and lipids
- Lipase if belly pain starts
- Weight and blood pressure, checked at home
Any family doctor can order these tests. If you prefer, private labs such as LifeLabs or Dynacare will run them for a fee. Repeat them roughly every 3 months.
Ordering in Canada
- Ships from inside Canada. No border, no customs hold.
- Tracking within 72 hours of payment. Weekend orders are packed on Sunday or Monday.
- Canada Post Xpresspost reaches most cities in 2–5 business days, and UPS or FedEx is faster still.
- Free shipping by Canada Post above $300, and by UPS or FedEx above $1,000.
- Plain packaging. No product names or branding appear on the box.
- Pay by Interac e-Transfer in Canadian dollars from your bank.
Common questions
Has it been approved?
Not yet. Phase 3 trials are still under way, and here it is sold as a research peptide.
How long does one vial last at the trial starting dose?
The vial holds 10 mg. At 2 mg a week, that covers 5 weeks.
Is Reta legal in Canada?
Health Canada has not approved Reta for human use. It is sold as a research peptide.
Sources
- A triple-hormone-receptor agonist for obesity: phase 2 trialJastreboff AM et al. · N Engl J Med · 2023 · PMID 37366315
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of conceptCoskun T et al. · Cell Metab · 2022 · PMID 35985340



